Clinical Trial: Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China

U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07135986) titled 'Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China' on Aug. 14.

Brief Summary: This is a Phase 3, modified double-blind, randomized, parallel-group, active-controlled, multicenter study with 2 arms and 4 groups to evaluate the immunogenicity and safety of MenACYW conjugate vaccine in children and adolescents versus control meningococcal vaccines licensed in China.

Study details include:

* The study duration will be approximately 180 days.

* The vaccination visit will be Visit 1.

* The visit frequency will be 2 on-site visits...